Feng Peng
Fujian Medical University(CN)Sichuan University(CN)Education Department of Fujian Province(CN)Sichuan Cancer Hospital(CN)First Affiliated Hospital of Fujian Medical University(CN)Zhuzhou Central Hospital(CN)Hangzhou DAC Biotech (China)(CN)Guangdong Ocean University(CN)Dalian Polytechnic University(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Gastric Cancer Management and Outcomes, Cancer, Lipids, and Metabolism, Pancreatic and Hepatic Oncology Research, Cancer-related molecular mechanisms research
Most-Cited Works
- → Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine(2000)235 cited
- → Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial(2018)214 cited
- → Immunogene therapy of tumors with vaccine based onXenopushomologous vascular endothelial growth factor as a model antigen(2001)112 cited
- → Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells(2014)111 cited
- → Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2(2003)108 cited
- → Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis